{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-028661","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.637952+00:00","generated_at":"2026-05-15T10:56:51.434525+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"other","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Incannex regains Nasdaq minimum bid price compliance; listing overhang removed","bullets":["Nasdaq confirmed compliance after IXHL closed at ≥$1.00 for 11 consecutive business days through March 13, 2026.","Company had previously disclosed bid price deficiency in April and October 2025; matter is now closed.","CEO Joel Latham highlighted $75M cash, no debt, and pipeline progress (IHL-42X, PSX-001).","Regaining compliance ensures continued listing on Nasdaq Capital Market, removing a technical overhang."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-028661","json":"https://secwatch.observer/filing/0001213900-26-028661.json","markdown":"https://secwatch.observer/filing/0001213900-26-028661.md","text":"https://secwatch.observer/filing/0001213900-26-028661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/ea0281000-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T10:56:51.434525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15a8173d639a8a7ec280a24e69a60bb61b2f2dcf","claim":"Incannex Healthcare Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"March 16, 2026, Incannex Healthcare Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which the Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025, has been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-060556","ticker":"COCH","company_name":"Envoy Medical, Inc.","filed_at":"2026-05-22T20:05:31+00:00","headline":"Envoy Medical receives Nasdaq extension to November 16, 2026 to cure bid price deficiency","event_type":"other","sec_items":["3.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-060556","json":"https://secwatch.observer/filing/0001213900-26-060556.json","markdown":"https://secwatch.observer/filing/0001213900-26-060556.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/ea0292043-8k_envoy.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"May 19, 2026, the Company received a second staff notification\nfrom Nasdaq informing the Company that, although the Company had not met the Bid Price Requirement by the Compliance Date, the Company\nis eligible for an add","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026060556/0001213900-26-060556-index.htm"}},{"accession":"0001731122-26-000781","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2026-05-22T12:15:26+00:00","headline":"Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000781","json":"https://secwatch.observer/filing/0001731122-26-000781.json","markdown":"https://secwatch.observer/filing/0001731122-26-000781.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/e7667_8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"May 20, 2026, Anavex Life Sciences Corp. (the “Company”)\nreceived a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market\nLLC (“Nasdaq”) indicating that, as","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226000781/0001731122-26-000781-index.htm"}},{"accession":"0001654954-26-004223","ticker":"ONFO","company_name":"Onfolio Holdings, Inc","filed_at":"2026-05-01T23:59:59+00:00","headline":"Onfolio Holdings regains Nasdaq minimum bid price compliance","event_type":"regulatory","sec_items":["3.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 8.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-004223","json":"https://secwatch.observer/filing/0001654954-26-004223.json","markdown":"https://secwatch.observer/filing/0001654954-26-004223.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426004223/0001654954-26-004223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426004223/onfo_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"January 6, 2026, Onfolio Holdings Inc. (the “ Company ”) received notice from The NASDAQ Stock Market that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days a","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1825452/000165495426004223/0001654954-26-004223-index.htm"}},{"accession":"0001628280-26-039190","ticker":"FTHM","company_name":"Fathom Holdings Inc.","filed_at":"2026-05-29T20:15:13+00:00","headline":"Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039190","json":"https://secwatch.observer/filing/0001628280-26-039190.json","markdown":"https://secwatch.observer/filing/0001628280-26-039190.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/0001628280-26-039190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/fthm-20260522.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1753162/000162828026039190/0001628280-26-039190-index.htm"}},{"accession":"0001493152-26-025087","ticker":"LASE","company_name":"Laser Photonics Corp","filed_at":"2026-05-22T21:27:31+00:00","headline":"Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-025087","json":"https://secwatch.observer/filing/0001493152-26-025087.json","markdown":"https://secwatch.observer/filing/0001493152-26-025087.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/0001493152-26-025087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"received a notice from Nasdaq Listing Qualifications\ndepartment of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q\nfor the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated\nthat the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception\nto allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or\nNovember 16, 2026. A\ncopy of t","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1807887/000149315226025087/0001493152-26-025087-index.htm"}},{"accession":"0001628280-26-037742","ticker":"RICK","company_name":"RCI HOSPITALITY HOLDINGS, INC.","filed_at":"2026-05-22T20:23:08+00:00","headline":"RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-037742","json":"https://secwatch.observer/filing/0001628280-26-037742.json","markdown":"https://secwatch.observer/filing/0001628280-26-037742.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/0001628280-26-037742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/rick-20260520.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/935419/000162828026037742/0001628280-26-037742-index.htm"}},{"accession":"0001493152-26-024913","ticker":"GTBP","company_name":"GT Biopharma, Inc.","filed_at":"2026-05-22T12:00:37+00:00","headline":"GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024913","json":"https://secwatch.observer/filing/0001493152-26-024913.json","markdown":"https://secwatch.observer/filing/0001493152-26-024913.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications\nStaff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226024913/0001493152-26-024913-index.htm"}},{"accession":"0001654954-26-004174","ticker":"AREC","company_name":"American Resources Corp","filed_at":"2026-04-30T23:59:59+00:00","headline":"American Resources receives Nasdaq non-compliance notice for late 10-K filing; has 60 days to submit plan","event_type":"regulatory","sec_items":["3.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-004174","json":"https://secwatch.observer/filing/0001654954-26-004174.json","markdown":"https://secwatch.observer/filing/0001654954-26-004174.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590715/000165495426004174/0001654954-26-004174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590715/000165495426004174/arec_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"March 16, 2026, Incannex Healthcare\nInc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)\nnotifying the Company that the bid price deficiency under Nasdaq Listing Rule 5550(a)(2) (the \"Minimum Bid Price Rule\"), which\nthe Company previously reported on in its Current Reports on Form 8-K filed on April 23, 2025 and Form 8-K filed on October 21, 2025,\nhas been cured, and that the Company is now in compliance with the Minimum Bid Price Rule.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1873875/000121390026028661/0001213900-26-028661-index.htm","comparable_excerpt":"April 24, 2026, American Resources Corporation (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to t","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1590715/000165495426004174/0001654954-26-004174-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}